OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early Tecovirimat Treatment for Mpox Disease Among People With HIV
Bruce Aldred, Robert H. Lyles, Jane Y. Scott, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 3, pp. 275-275
Closed Access | Times Cited: 16
Bruce Aldred, Robert H. Lyles, Jane Y. Scott, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 3, pp. 275-275
Closed Access | Times Cited: 16
Showing 16 citing articles:
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies
Boghuma K Titanji, Aniruddha Hazra, Jason Zucker
JAMA (2024) Vol. 332, Iss. 19, pp. 1652-1652
Closed Access | Times Cited: 11
Boghuma K Titanji, Aniruddha Hazra, Jason Zucker
JAMA (2024) Vol. 332, Iss. 19, pp. 1652-1652
Closed Access | Times Cited: 11
Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023
Patricia Yu, Riad Elmor, Kalimah Muhammad, et al.
NEJM Evidence (2024)
Closed Access | Times Cited: 9
Patricia Yu, Riad Elmor, Kalimah Muhammad, et al.
NEJM Evidence (2024)
Closed Access | Times Cited: 9
Mpox in people with HIV : A narrative review
Hideta Nakamura, Kazuko Yamamoto
HIV Medicine (2024) Vol. 25, Iss. 8, pp. 910-918
Open Access | Times Cited: 5
Hideta Nakamura, Kazuko Yamamoto
HIV Medicine (2024) Vol. 25, Iss. 8, pp. 910-918
Open Access | Times Cited: 5
Mpox primer for clinicians: what makes the difference in 2024?
Sama Mahmoud Abdel‐Rahman, Büşra Zeynep Bayıcı, Şiran Keske, et al.
Current Opinion in Infectious Diseases (2025)
Closed Access
Sama Mahmoud Abdel‐Rahman, Büşra Zeynep Bayıcı, Şiran Keske, et al.
Current Opinion in Infectious Diseases (2025)
Closed Access
Tecovirimat in the management of poxviruses: a narrative review of available evidence
Olalekan John Okesanya, Jerico Bautista Ogaya, Ikponmwosa Jude Ogieuhi, et al.
The Egyptian Journal of Internal Medicine (2025) Vol. 37, Iss. 1
Open Access
Olalekan John Okesanya, Jerico Bautista Ogaya, Ikponmwosa Jude Ogieuhi, et al.
The Egyptian Journal of Internal Medicine (2025) Vol. 37, Iss. 1
Open Access
Early clinical experience using tecovirimat during the 2022 mpox epidemic in Toronto underscores ongoing clinical equipoise and the need for randomized trials
Shreya S Khera, Sharmistha Mishra, Oscar Javier Pico Espinosa, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Shreya S Khera, Sharmistha Mishra, Oscar Javier Pico Espinosa, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Therapeutic agents for the treatment of human mpox
Maxwell Braddick, Kasha P. Singh
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 518-525
Closed Access | Times Cited: 4
Maxwell Braddick, Kasha P. Singh
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 518-525
Closed Access | Times Cited: 4
Tecovirimat for Mpox—Promise and Limitations
Jason Zucker, William A. Fischer, Timothy Wilkin
JAMA Internal Medicine (2024) Vol. 184, Iss. 3, pp. 279-279
Closed Access | Times Cited: 3
Jason Zucker, William A. Fischer, Timothy Wilkin
JAMA Internal Medicine (2024) Vol. 184, Iss. 3, pp. 279-279
Closed Access | Times Cited: 3
Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City
Elizabeth A. Garcia, Mary M K Foote, Tristan D. McPherson, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 3
Elizabeth A. Garcia, Mary M K Foote, Tristan D. McPherson, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 3
Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis against mpox in a High-Risk Population: An Open-Label Randomized Trial
Nobumasa Okumura, Eriko Morino, Hidetoshi Nomoto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Nobumasa Okumura, Eriko Morino, Hidetoshi Nomoto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV
Yu-Hsin Ting, Yu-Che Lee, Ko-Yun Chang
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 706-706
Closed Access | Times Cited: 1
Yu-Hsin Ting, Yu-Che Lee, Ko-Yun Chang
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 706-706
Closed Access | Times Cited: 1
Necrotizing mpox with persistent microbiological positivity despite the use of tecovirimat: A case report
Pierluigi Francesco Salvo, Gianmaria Baldin, Elena Visconti, et al.
Travel Medicine and Infectious Disease (2024) Vol. 61, pp. 102746-102746
Open Access | Times Cited: 1
Pierluigi Francesco Salvo, Gianmaria Baldin, Elena Visconti, et al.
Travel Medicine and Infectious Disease (2024) Vol. 61, pp. 102746-102746
Open Access | Times Cited: 1
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)
Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
EBioMedicine (2024) Vol. 107, pp. 105289-105289
Open Access | Times Cited: 1
Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
EBioMedicine (2024) Vol. 107, pp. 105289-105289
Open Access | Times Cited: 1
Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV—Reply
Bruce Aldred, Robert H. Lyles, Valeria D Cantos
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 706-706
Closed Access
Bruce Aldred, Robert H. Lyles, Valeria D Cantos
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 706-706
Closed Access
Mpox re-emerges: Historical background, symptom overview, and contemporary treatment options
David Banji, Otilia J.F. Banji
Journal of Acute Disease (2024) Vol. 13, Iss. 4, pp. 127-134
Open Access
David Banji, Otilia J.F. Banji
Journal of Acute Disease (2024) Vol. 13, Iss. 4, pp. 127-134
Open Access
Effectiveness of Tecovirimat in Mpox Cases: A Systematic Review of Current Evidence
Muhammed Shabil, Mahalaqua Nazli Khatib, Suhas Ballal, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 12
Closed Access
Muhammed Shabil, Mahalaqua Nazli Khatib, Suhas Ballal, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 12
Closed Access
